Skip to main content
Erschienen in: Infection 3/2020

25.02.2020 | Original Paper

Left-sided infective endocarditis in persons who inject drugs

verfasst von: Glen Huang, Kyle A. Davis, S. Allan Petty, Walter A. Tan, Erin W. Barnes, James E. Peacock Jr.

Erschienen in: Infection | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to describe left-sided infective endocarditis (LSIE) in persons who inject drugs (PWID) and compare that group to PWID with non-LSIE and to non-PWID with LSIE.

Methods

Retrospective single-center study of adult IE patients from 2011 to 2018.

Results

Of the 333 patients in our cohort, 54 were PWID with LSIE, 75 were PWID with non-LSIE, and 204 were non-PWID with LSIE. When comparing LSIE vs non-LSIE in PWID, the LSIE group was older (median age 35 vs 28.5, p < 0.01), had fewer S. aureus infections (59% vs 92%, p < 0.01), was more likely to have cardiac surgery (31% vs 13%, p < 0.01), and had a higher 10-week mortality (22% vs 5%, p < 0.01). When comparing PWID with LSIE to non-PWID with LSIE, the PWID group were younger (median age 35 vs 46, p < 0.01); had more frequent multi-valve involvement (33% vs 19%, p = 0.04), Staphylococcus aureus infections (54% vs 27%, p < 0.01), and previous IE (24% vs 8%, p < 0.01); and experienced more strokes (54% vs 31%, p < 0.01). Ten-week mortality was similar for LSIE in both PWID and non-PWID (24% vs 20%, p = 0.47).

Conclusions

LSIE in PWID is not uncommon. Compared to non-LSIE in PWID, valve surgery is more common and mortality is higher. For reasons that are unclear, stroke is more frequent in LSIE in PWID than in non-PWID with LSIE but mortality is no different.
Literatur
3.
5.
Zurück zum Zitat Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the southeastern United States. Am J Med Sci. 2016;352:603–8.CrossRefPubMedPubMedCentral Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the southeastern United States. Am J Med Sci. 2016;352:603–8.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fleischauer AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence—North Carolina, 2010–2015. MMWR Morb Mortal Wkly Rep. 2017;66:569–73.CrossRefPubMedPubMedCentral Fleischauer AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence—North Carolina, 2010–2015. MMWR Morb Mortal Wkly Rep. 2017;66:569–73.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am. 2002;16:273–95.CrossRef Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am. 2002;16:273–95.CrossRef
15.
Zurück zum Zitat Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155:1641–8.CrossRefPubMed Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155:1641–8.CrossRefPubMed
18.
Zurück zum Zitat Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540–6.CrossRefPubMed Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540–6.CrossRefPubMed
20.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128. https://doi.org/10.1093/eurheartj/ehv319.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128. https://​doi.​org/​10.​1093/​eurheartj/​ehv319.CrossRefPubMed
22.
Zurück zum Zitat Miro JM, Moreno A, Mestres CA. Infective endocarditis in intravenous drug abusers. Curr Infect Dis Rep. 2003;5:307–16.CrossRefPubMed Miro JM, Moreno A, Mestres CA. Infective endocarditis in intravenous drug abusers. Curr Infect Dis Rep. 2003;5:307–16.CrossRefPubMed
28.
Zurück zum Zitat Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis. Risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–84.CrossRefPubMed Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis. Risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–84.CrossRefPubMed
29.
Zurück zum Zitat Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis. Construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013;62:1384–92.CrossRefPubMed Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis. Construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013;62:1384–92.CrossRefPubMed
32.
Zurück zum Zitat Carozza A, De Santo LS, Romano G, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–31.PubMed Carozza A, De Santo LS, Romano G, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–31.PubMed
Metadaten
Titel
Left-sided infective endocarditis in persons who inject drugs
verfasst von
Glen Huang
Kyle A. Davis
S. Allan Petty
Walter A. Tan
Erin W. Barnes
James E. Peacock Jr.
Publikationsdatum
25.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 3/2020
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01402-x

Weitere Artikel der Ausgabe 3/2020

Infection 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.